Blood Screening Market Trends, Share, Key Players and Forecast Report, 2030

1. Blood Screening Market to Grow at CAGR of 8.1% during 2020–2030

2. Due to the increasing number of blood donors, rising prevalence of infectious, respiratory, and chronic diseases, rapid technological advancements, growing implementation of strict policies aimed at tracking blood contamination levels, and the surging healthcare expenditure, the global blood screening market attained a value of $2,402.3 million in 2019 and is expected to advance at 8.1% CAGR from 2020 to 2030. Explore report sample at: https://www.psmarketresearch.com/market-analysis/blood-screening-market/report-sample “

3. Software and services, instruments, and reagents and kits are the main categories present under the product type segment of the blood screening market. Out of these, the reagents and kits category is expected to lead the market in the future years, on account of the utilization of these products in the first phase of the screening process. Further, the increasing utilization of reagents and kits for the faster detection of various transfusion-transmissible diseases (TTD) will boost the growth of this category in the market in the coming years. Under the technology segmentation of the blood screening market, the main categories are enzyme-linked immunosorbent assay (ELISA), western blotting, rapid testing, next-generation sequencing, and nucleic acid technology (NAT). Amongst these, the nucleic acid technology (NAT) category accounted for the largest market share during 2014—2019 (historical period). This is ascribed to the higher sensitivity displayed by this technology than the other technologies and the subsequent adoption of this technology in blood testing centers.

4. In the near future, the Asia-Pacific (APAC) blood screening market is expected to exhibit the fastest growth, on account of the increasing presence of leading market players, rising incidence of various chronic diseases such as cancer, and the presence of an affordable labor force in the region. According to the findings of the Global Cancer Observatory (GLOBOCAN), 2,003,789 people were diagnosed with cancer in Southeast Asia in 2018. The players operating in the global blood screening market are increasingly focusing on frequent product launches in order to provide the customers with advanced and innovative blood testing solutions. Browse full report at: https://www.psmarketresearch.com/market-analysis/blood-screening-market

5. For example, Bio-Techne Corporation launched the QuantikineQuicKit ELISA product line in February 2020. These next-generation ELISA products increase the performance capabilities of the Quantikine ELISA kits and allow researchers to attain better results while maintaining the existing quality levels. These kits would allow healthcare providers to accurately determine the protein level in plasma, cell supernates, and serum in only 90 minutes. Pre-Purchase Inquiry at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=blood-screening-market

6. The prominent players operating in the global blood screening market are Abbott Laboratories, Danaher Corporation, PerkinElmer IncandbioMérieux SA, Siemens AG, DiaSorin S.p.A, Entwicklung und Distribution von DiagnostikaimBlutspendewesenmbH (GFE), Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories Inc., Trinity Biotech plc, Gesellschaft zurForschung, General Electric Company, J. Mitra & Co. Pvt. Ltd., Becton, Dickinson and Company, Bio-Techne Corporation, Merck KGaA, Ortho-Clinical Diagnostics Inc., and Grifols S.A.

7. THANK YOU! For queries, kindly write to: enquiry@psmarketresearch.com GET IN TOUCH www.psmarketresearch.com B-13, Sector-2, Noida, U.P.-201301, INDIA Contact No: +91 120 4541 337 US/Canada Toll-Free: 1-888-778-7886 US/Canada Toll-Free: 1-888-778-7886